Shanmugam Muthusamy 4
4 · ANI PHARMACEUTICALS INC · Filed Aug 18, 2025
Insider Transaction Report
Form 4
Shanmugam Muthusamy
DirectorHEAD OF R&D, COO-NOVITIUM OPS
Transactions
- Sale
Common Stock
2025-08-15$87.15/sh−52,990$4,618,079→ 531,920 total(indirect: By LLC) - Sale
Common Stock
2025-08-14$89.48/sh−47,010$4,206,455→ 584,910 total(indirect: By LLC)
Holdings
- 5,000(indirect: By LLC)
Common Stock
- 92,588
Common Stock
Footnotes (4)
- [F1]The shares were sold in multiple trades at prices ranging from $88.20 to $90.11. The price reported above reflects the weighted average sales price.
- [F2]The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
- [F3]The shares were sold in multiple trades at prices ranging from $85.44 to $90.00. The price reported above reflects the weighted average sales price.
- [F4]The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC.